Cargando…

Structural characterization of two solvates of a luminescent copper(II) bis­(pyridine)-substituted benzimidazole complex

Copper(II) complexes of benzimidazole are known to exhibit biological activity that makes them of inter­est for chemotherapeutic and other pharmaceutical uses. The complex bis­(acetato-κO){5,6-dimethyl-2-(pyridin-2-yl)-1-[(pyridin-2-yl)meth­yl]-1H-benzimidazole-κ(2) N (2),N (3)}copper(II), has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, David K., DeStefano, Matthew R., Lewis, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683476/
https://www.ncbi.nlm.nih.gov/pubmed/29152336
http://dx.doi.org/10.1107/S2056989017014232
Descripción
Sumario:Copper(II) complexes of benzimidazole are known to exhibit biological activity that makes them of inter­est for chemotherapeutic and other pharmaceutical uses. The complex bis­(acetato-κO){5,6-dimethyl-2-(pyridin-2-yl)-1-[(pyridin-2-yl)meth­yl]-1H-benzimidazole-κ(2) N (2),N (3)}copper(II), has been prepared. The absorption spectrum has features attributed to intra­ligand and ligand-field transitions and the complex exhibits ligand-centered room-temperature luminescence in solution. The aceto­nitrile monosolvate, [Cu(C(2)H(3)O(2))(2)(C(20)H(18)N(4))]·C(2)H(3)N (1), and the ethanol hemisolvate, [Cu(C(2)H(3)O(2))(2)(C(20)H(18)N(4))]·0.5C(2)H(6)O (2), have been structurally characterized. Compound 2 has two copper(II) complexes in the asymmetric unit. In both 1 and 2, distorted square-planar N(2)O(2) coordination geometries are observed and the Cu—N(Im) bond distance is slightly shorter than the Cu—N(py) bond distance. Inter­molecular π–π inter­actions are found in 1 and 2. A weak C—H⋯π inter­action is observed in 1.